Realbotix Corp. Provides Corporate Structure and Operations Update

Employee Count

Realbotix LLC employs approximately 25 staff dedicated to commercial robotics.

Ownership of RealDoll

86%

Intima LLC holds an 86% ownership stake in RealDoll, a company in the adult wellness market.

Expected Merger Completion

Second half of 2026

The merger with Onconetix, Inc. is anticipated to close in the second half of 2026.

§ 01 Executive Snapshot

What: Realbotix Corp. provides an update on its corporate structure and operations.
Who: Realbotix Corp., Realbotix LLC, Intima LLC, Andrew Kiguel (CEO).
Why it matters: The clarity on the operational structure and the separation of business lines underscores Realbotix's commitment to its core markets and addresses misinformation in media.

Realbotix Corp. operates as a holding company with two subsidiaries: Realbotix LLC and Intima LLC, each with distinct management and product strategies.
Realbotix LLC focuses on AI-powered humanoid robotics for commercial applications in sectors like healthcare and education, employing approximately 25 dedicated staff.
A planned merger with Onconetix, Inc. is expected to close in the second half of 2026, allowing Realbotix LLC and Intima LLC to operate as independent public companies.

The separation of Realbotix LLC and Intima LLC reflects a broader trend in the tech industry where companies are focusing on niche markets to enhance operational efficiency and brand clarity.
This update aims to mitigate recent inaccurate media portrayals, reinforcing Realbotix's commitment to ethical and compliant technological advancements in robotics.

The operational clarity may enhance investor confidence and attract potential partnerships in the commercial robotics sector.
Long-term, the planned independence of the two subsidiaries could allow for specialized growth strategies tailored to their respective markets.

Potential risks include regulatory scrutiny related to AI technologies and the complexities of the proposed merger with Onconetix.
Competition in the commercial robotics and AI sectors may pose challenges to Realbotix LLC's market positioning and growth.

The merger with Onconetix is a key milestone, with expected completion in the second half of 2026.
Monitoring media coverage and public perception will be crucial for Realbotix to address misinformation and maintain its reputation in the market.

§ 07

What is the main focus of Realbotix LLC?

Realbotix LLC focuses on AI-powered humanoid robotics for commercial applications in sectors like healthcare and education.

Why is the separation of Realbotix LLC and Intima LLC important?

The separation reflects a broader trend in the tech industry to enhance operational efficiency and brand clarity.

When is the planned merger with Onconetix expected to close?

The planned merger with Onconetix is expected to close in the second half of 2026.

Who is the CEO of Realbotix Corp.?

Andrew Kiguel is the CEO of Realbotix Corp.